Amit Sachdev

2019

In 2019, Amit Sachdev earned a total compensation of $6.2M as EVP & Chief Patient Officer at Vertex Pharmaceuticals, a 9% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$823,292
Option Awards$1,575,011
Salary$540,750
Stock Awards$3,215,952
Other$42,048
Total$6,197,053

Sachdev received $3.2M in stock awards, accounting for 52% of the total pay in 2019.

Sachdev also received $823.3K in non-equity incentive plan, $1.6M in option awards, $540.8K in salary and $42K in other compensation.

Rankings

In 2019, Amit Sachdev's compensation ranked 1,628th out of 13,971 executives tracked by ExecPay. In other words, Sachdev earned more than 88.3% of executives.

ClassificationRankingPercentile
All
1,628
out of 13,971
88th
Division
Manufacturing
582
out of 5,701
90th
Major group
Chemicals And Allied Products
175
out of 2,200
92nd
Industry group
Drugs
141
out of 1,886
93rd
Industry
Pharmaceutical Preparations
106
out of 1,398
92nd
Source: SEC filing on April 28, 2020.

Sachdev's colleagues

We found six more compensation records of executives who worked with Amit Sachdev at Vertex Pharmaceuticals in 2019.

2019

Jeffrey Leiden

Vertex Pharmaceuticals

Chairman

2019

Stuart Arbuckle

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

2019

Reshma Kewalramani

Vertex Pharmaceuticals

Chief Executive Officer

2019

Charles Wagner

Vertex Pharmaceuticals

Chief Financial Officer

2019

Paul Silva

Vertex Pharmaceuticals

SVP & Corporate Controller

2019

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

News

You may also like